Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events. (Q53694789)
Jump to navigation
Jump to search
scientific article published on 23 March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events. |
scientific article published on 23 March 2018 |
Statements
1 reference
Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events. (English)
1 reference
Mitsuhiko Moriyama
1 reference
Tatsuo Kanda
1 reference
Shin Yasui
1 reference
Masato Nakamura
1 reference
Shingo Nakamoto
1 reference
Koji Takahashi
1 reference
Shuang Wu
1 reference
Reina Sasaki
1 reference
Yuki Haga
1 reference
Sadahisa Ogasawara
1 reference
Tomoko Saito
1 reference
Kazufumi Kobayashi
1 reference
Soichiro Kiyono
1 reference
Yoshihiko Ooka
1 reference
Eiichiro Suzuki
1 reference
Tetsuhiro Chiba
1 reference
Hitoshi Maruyama
1 reference
Naoya Kato
1 reference
23 March 2018
1 reference
1 reference
9
1 reference
16263-16270
1 reference
22
1 reference
Identifiers
1 reference
1 reference